IMO, all is data dependant,in that regard, Aipac is the likely first out-licence
however the EMA is the wild card......If they as stated before, approve "efti"
in Aipac for early commercialisation,depending on Aipac data Q4/19
or Q1/20 there is a possibility of something material happening Q2/20.....
Bearing in mind, we are funded up to mid year/20....
Ann: Webcast slides for eftilagimod alpha (IMP321), page-38
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.3M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 30.5¢ | $451.9K | 1.449M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26980 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 46868 | 3 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |